Clinical Significance of PCSK9 and Soluble P-selectin in Predicting Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
Objective: This study aimed at investigating the association of proprotein convertase subtilisin/kexin type 9 (PCSK9) with soluble P-selectin (sP-selectin), and their values in predicting major adverse cardiovascular events (MACE) at 1-year follow-up in patients with acute coronary syndrome (ACS) r...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2024-01-01
|
Series: | Cardiovascular Innovations and Applications |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2023.0087 |